Moderna reports Covid vaccine is 95% effective, can be stored at higher temperatures

Moderna Inc.’s Covid-19 vaccine may be both more effective than Pfizer’s leading candidate, and easier to store and distribute, according to an analysis of new data released Monday. The Cambridge-based biotech’s vaccine is 94.5% effective at preventing Covid-19, according to an early look at the company’s Phase 3 trial. The 30,000-person study is one of the largest ever conducted and marks the final test of Moderna’s drug before it can be submitted to the FDA for approval. Today's analysis…

Click to view original post